These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10332667)

  • 1. Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.
    Margolis DJ; Kantor J; Berlin JA
    Diabetes Care; 1999 May; 22(5):692-5. PubMed ID: 10332667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis.
    Margolis DJ; Kantor J; Santanna J; Strom BL; Berlin JA
    Arch Dermatol; 2000 Dec; 136(12):1531-5. PubMed ID: 11115166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing diabetic neuropathic foot ulcers: are we getting better?
    Margolis DJ; Allen-Taylor L; Hoffstad O; Berlin JA
    Diabet Med; 2005 Feb; 22(2):172-6. PubMed ID: 15660734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic neuropathic forefoot and heel ulcers: management, clinical presentation and outcomes.
    Yosuf MK; Mahadi SI; Mahmoud SM; Widatalla AH; Ahmed ME
    J Wound Care; 2015 Sep; 24(9):420-5. PubMed ID: 26349023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial.
    Sheehan P; Jones P; Caselli A; Giurini JM; Veves A
    Diabetes Care; 2003 Jun; 26(6):1879-82. PubMed ID: 12766127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epidermal growth factor enhances healing of diabetic foot ulcers.
    Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK
    Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total contact cast for neuropathic diabetic foot ulcers.
    Ali R; Qureshi A; Yaqoob MY; Shakil M
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):695-8. PubMed ID: 18983793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing.
    Margolis DJ; Allen-Taylor L; Hoffstad O; Berlin JA
    Diabetes Care; 2002 Oct; 25(10):1835-9. PubMed ID: 12351487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of applied felted foam on wound healing and healing times in the therapy of neuropathic diabetic foot ulcers.
    Zimny S; Schatz H; Pfohl U
    Diabet Med; 2003 Aug; 20(8):622-5. PubMed ID: 12873288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers.
    Zimny S; Schatz H; Pfohl M
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):191-4. PubMed ID: 15127323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial.
    Game F; Jeffcoate W; Tarnow L; Day F; Fitzsimmons D; Jacobsen J
    Trials; 2017 Oct; 18(1):469. PubMed ID: 29017535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants and estimation of healing times in diabetic foot ulcers.
    Zimny S; Schatz H; Pfohl M
    J Diabetes Complications; 2002; 16(5):327-32. PubMed ID: 12200075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area.
    Ince P; Game FL; Jeffcoate WJ
    Diabetes Care; 2007 Mar; 30(3):660-3. PubMed ID: 17327337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous oxygen pressure measurement in diabetic foot ulcers: mean values and cut-point for wound healing.
    Yang C; Weng H; Chen L; Yang H; Luo G; Mai L; Jin G; Yan L
    J Wound Ostomy Continence Nurs; 2013; 40(6):585-9. PubMed ID: 24202221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type.
    Yotsu RR; Pham NM; Oe M; Nagase T; Sanada H; Hara H; Fukuda S; Fujitani J; Yamamoto-Honda R; Kajio H; Noda M; Tamaki T
    J Diabetes Complications; 2014; 28(4):528-35. PubMed ID: 24846054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of the PUSH tool in diabetic foot ulcers.
    Gardner SE; Hillis SL; Frantz RA
    J Wound Ostomy Continence Nurs; 2011; 38(4):385-93. PubMed ID: 21606864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.